(Q52956179)

9 May 2018

title

Nanostructured lipid matrices for improved microencapsulation of drugs. (English)

1 reference

9 May 2018

1 reference

Müller RH

1

1 reference

9 May 2018

Radtke M

series ordinal

2

1 reference

9 May 2018

Wissing SA

series ordinal

3

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 August 2002

1 reference

9 May 2018

number of pages

8

1 reference

International Journal of Pharmaceutics

inferred from page(s)

published in

1 reference

9 May 2018

volume

242

1 reference

9 May 2018

issue

1-2

1 reference

9 May 2018

page(s)

121-128

1 reference

9 May 2018

Optimization of spray-dried and -congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900180-1

7 January 2021

Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900180-1

7 January 2021

Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900180-1

7 January 2021

Encapsulation of retinoids in solid lipid nanoparticles (SLN).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900180-1

7 January 2021

Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900180-1

7 January 2021

Solid lipid nanoparticles: production, characterization and applications

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900180-1

7 January 2021

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900180-1

7 January 2021

Body distribution of camptothecin solid lipid nanoparticles after oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900180-1

7 January 2021

Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900180-1

7 January 2021

Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900180-1

7 January 2021

Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900180-1

7 January 2021

10.1016/S0378-5173(02)00180-1

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018